Correlation Between Cellnex Telecom and Biotechnology Assets

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cellnex Telecom and Biotechnology Assets at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cellnex Telecom and Biotechnology Assets into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cellnex Telecom SA and Biotechnology Assets SA, you can compare the effects of market volatilities on Cellnex Telecom and Biotechnology Assets and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cellnex Telecom with a short position of Biotechnology Assets. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cellnex Telecom and Biotechnology Assets.

Diversification Opportunities for Cellnex Telecom and Biotechnology Assets

-0.02
  Correlation Coefficient

Good diversification

The 3 months correlation between Cellnex and Biotechnology is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Cellnex Telecom SA and Biotechnology Assets SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Assets and Cellnex Telecom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cellnex Telecom SA are associated (or correlated) with Biotechnology Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Assets has no effect on the direction of Cellnex Telecom i.e., Cellnex Telecom and Biotechnology Assets go up and down completely randomly.

Pair Corralation between Cellnex Telecom and Biotechnology Assets

Assuming the 90 days trading horizon Cellnex Telecom SA is expected to under-perform the Biotechnology Assets. But the stock apears to be less risky and, when comparing its historical volatility, Cellnex Telecom SA is 3.98 times less risky than Biotechnology Assets. The stock trades about -0.05 of its potential returns per unit of risk. The Biotechnology Assets SA is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  31.00  in Biotechnology Assets SA on September 5, 2024 and sell it today you would earn a total of  0.00  from holding Biotechnology Assets SA or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cellnex Telecom SA  vs.  Biotechnology Assets SA

 Performance 
       Timeline  
Cellnex Telecom SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cellnex Telecom SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Cellnex Telecom is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Biotechnology Assets 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Assets SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Biotechnology Assets may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Cellnex Telecom and Biotechnology Assets Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cellnex Telecom and Biotechnology Assets

The main advantage of trading using opposite Cellnex Telecom and Biotechnology Assets positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cellnex Telecom position performs unexpectedly, Biotechnology Assets can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Assets will offset losses from the drop in Biotechnology Assets' long position.
The idea behind Cellnex Telecom SA and Biotechnology Assets SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance